Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Real-time Estimate Tradegate
Other stock markets
 07:36:00 2024-06-03 am EDT 		5-day change 1st Jan Change
125 EUR +0.77% Intraday chart for Neurocrine Biosciences, Inc. -3.29% +5.09%
May. 31 Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing MT
May. 28 Neurocrine Biosciences Says CEO Kevin Gorman Retiring MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. Charts Neurocrine Biosciences, Inc.
  6. Sector Chart